Thanks for your interest in OnTracx!

Big news from our team 🚀 We’ve raised €1.2M ($1.4M) in seed funding to continue our mission.

Our smart lower-leg sensor measures the real impact on tendons, muscles, and joints — where most running injuries occur. Through our platform, athletes and professionals finally gain actionable insights into the body’s true load, an area many experts have long identified as key to better outcomes.

Since launching in 2024, more than 500 runners and 20+ sports medical centers have joined us. With this new investment, we’ll refine our product, expand internationally, and integrate with leading running apps and wearables.

💡 All necessary information — press release, visuals, and team details — can be found below.

👉 For interviews or questions: [email protected] (+32472627007)

🌍 More: www.ontracx.com

1. About OnTracx

OnTracx overview

Key Highlights

• Raised €1.2M ($1.4M) seed round to accelerate product development and market expansion in Europe and the U.S.
• First solution to turn validated sensor data into unique, lab-backed insights, developed at Ghent University, helping runners and professionals train smarter and return from injury more safely.
• Bridges care, training, and performance by turning complex movement data into clear, actionable insights.
• Early traction: 500+ sensors sold and 20 sports medical centers onboard since April 2024.
• Backed by leading investors including imec.istart fund, PMV, KBC, business angels with sports medicine and entrepreneurial expertise, and a VLAIO innovation grant.

2. Press Release

🇺🇸 Press Release (EN)

Persbericht (BE)